7 minute read

Mar. 31, 2024

Patent Highlights: Synthetic Lethal MTA-Cooperative PRMT5 Inhibitors, TYK2 Degraders, Mutant p53 Reactivators, and More

Authors:

Vinicius Teixeira,

Shaima Qunies

Reviewers:

Dennis C. Koester,

Lew Pennington

Editor:

Other articles you may be interested in